| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director
2 companies
Brainard Diana is a Chief Executive Officer at Kalaris Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $5.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 3, 2023 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 1,325 | $1.98 | $2,618.60 | -0.1% | -66.4% | -59.8% | |
| Aug 18, 2023 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 15,416 | $2.57 | $39,664.01 | -0.9% | -41.9% | -73.8% | |
| Jul 19, 2023 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 8,342 | $3.56 | $29,710.03 | -0.9% | -50.3% | -77.6% | |
| Jul 5, 2023 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 5,275 | $3.05 | $16,062.90 | -0.6% | -35.7% | -78.1% | |
| May 18, 2023 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 4,536 | $4.21 | $19,114.70 | -0.5% | -36.3% | -81.1% | |
| Apr 19, 2023 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 8,408 | $3.71 | $31,182.75 | -0.9% | -8.1% | -80.7% | |
| Feb 21, 2023 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 5,122 | $6.63 | $33,935.30 | -0.5% | -32.4% | -88.9% | |
| Jan 19, 2023 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 34,435 | $5.08 | $174,850.60 | -5.4% | -24.8% | -86.7% | |
| Nov 18, 2022 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 4,515 | $7.27 | $32,810.05 | -0.7% | -16.3% | -77.9% | |
| Aug 18, 2022 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 4,564 | $7.76 | $35,428.51 | -0.7% | -3.8% | -63.7% |